Neuropathology

  • Arie Perry
  • Bernd W. Scheithauer
Chapter

Keywords

Glial Fibrillary Acidic Protein Multiple System Atrophy Progressive Multifocal Leukoencephalopathy Spinal Muscular Atrophy Cerebral Spinal Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Gliomas

  1. 1.
    Brat DJ, Scheithauer BW, Staugaitis SM, Cortez SC, Brecher K, Burger PC. Third ventricular chordoid glioma: A distinct clinicopathologic entity. J Neuropathol Exp Neurol. 1998;57:283–290.PubMedCrossRefGoogle Scholar
  2. 2.
    Burger PC. Pathology of brain stem astrocytomas. Pediatr Neurosurg. 1996;24:35–40.PubMedCrossRefGoogle Scholar
  3. 3.
    Burger PC, Pearl DK, Aldape K, et al. Small cell architecture-A histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol. 2001;60:1099–1104.PubMedGoogle Scholar
  4. 4.
    Choi YL, Chi JG, Suh YL. CD99 immunoreactivity in ependymoma. Appl Immunohistochem Mol Morphol. 2001;9:125–129.PubMedCrossRefGoogle Scholar
  5. 5.
    Ernestus RI, Schroder R, Stutzer H, et al. The clinical and prognostic relevance of grading in intracranial ependymomas. Br J Neurosurg. 1997;11:421–428.PubMedCrossRefGoogle Scholar
  6. 6.
    Fernandez C, Figarella-Branger D, Girard N, et al. Pilocytic astrocytomas in children: Prognostic factors-A retrospective study of 80 cases. Neurosurgery. 2003;53:544–555.PubMedCrossRefGoogle Scholar
  7. 7.
    Giannini C, Scheithauer BW, Burger PC, et al. Pleomorphic xanthoastrocytoma. What do we really know about it? Cancer. 1999;85:2033–2045.PubMedGoogle Scholar
  8. 8.
    Hirose T, Scheithauer BW, Lopes MBS, et al. Tuber and sub-ependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron microscopic study. Acta Neuropathol. 1995;90:387–399.PubMedCrossRefGoogle Scholar
  9. 9.
    Kepes JJ. Pleomorphic xanthoastrocytoma: the birth of a diagnosis and a concept. Brain Pathol. 1993;3:269–274.PubMedCrossRefGoogle Scholar
  10. 10.
    Kleihues P, Cavenee WK eds. WHO classification of tumors. In: Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press; 2000.Google Scholar
  11. 11.
    Komotar RJ, Burger PC, Carson BS, et al. Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery. 2004;54:72–80.PubMedCrossRefGoogle Scholar
  12. 12.
    Min KW, Scheithauer BW. Clear cell ependymoma: a mimic of oligodendroglioma: clinicopathologic and ultrastructural considerations. Am J Surg Pathol. 1997;21:820–826.PubMedCrossRefGoogle Scholar
  13. 13.
    Perry A. Oligodendroglial neoplasms: current concepts, misconceptions, and folklore. Adv Anatomic Pathol. 2001;8:183–199.CrossRefGoogle Scholar
  14. 14.
    Perry A. Pathology of low-grade gliomas. An update of emerging concepts. Neuro-Oncology. 2003;5:168–178.PubMedCrossRefGoogle Scholar
  15. 15.
    Reifenberger G, Kaulich K, Wiestler OD, Blumcke I. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas. Acta Neuropathol. 2003;105:358–364.PubMedGoogle Scholar
  16. 16.
    Rosenblum MK. Ependymal tumors: A review of their diagnostic surgical pathology. Pediatr Neurosurg. 1998;28:160–165.PubMedCrossRefGoogle Scholar
  17. 17.
    Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer. 1985;56:883–893.PubMedCrossRefGoogle Scholar
  18. 18.
    Sato K, Kubota T, Ishida M, Yoshida K, Takeuchi H, Handa Y. Immunohistochemical and ultrastructural study of chordoid glioma of the third ventricle: its tanycytic differentiation. Acta Neuropathol. 2003;106:176–180.PubMedCrossRefGoogle Scholar
  19. 19.
    Vege KDS, Giannini C, Scheithauer BW. The immunophenotype of ependymomas. Appl Immunohistochem Mol Morphol. 2000;8:25–31.PubMedCrossRefGoogle Scholar

Neuronal/Glioneuronal Neoplasms

  1. 1.
    Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, et al. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery. 1988;23:545–556.PubMedCrossRefGoogle Scholar
  2. 2.
    Eberhart CG, Burger PC. Anaplasia and grading in medulloblastomas. Brain Pathol. 2003;13:376–385.PubMedCrossRefGoogle Scholar
  3. 3.
    Fuller CE, Pfeifer J, Humphrey P, Bruch LA, Dehner LP, Perry A. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic? Hum Pathol. 2001;32:1102–1108.PubMedCrossRefGoogle Scholar
  4. 4.
    Giangaspero F, Perilongo G, Fondelli MP, et al. Medulloblastoma with extensive nodularity: A variant with favorable prognosis. J Neurosurg. 1999;91:971–977.PubMedCrossRefGoogle Scholar
  5. 5.
    Hassoun J, Söylemezoglu F, Gambarelli D, et al. Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol. 1993;3:297–306.PubMedCrossRefGoogle Scholar
  6. 6.
    Hirose T, Scheithauer BW, Lopes MBS, et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer. 1995;76:4–19.PubMedCrossRefGoogle Scholar
  7. 7.
    Ho DMT, Hsu CY, Wong TT, Ting LT, Chiang H. Atypical teratoid/rhabdoid tumor of the central nervous system: A comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol. 2000;99:482–488.PubMedCrossRefGoogle Scholar
  8. 8.
    Honavar M, Janota I, Polkey CE. Histological heterogeneity of dysembryoplastic neuroepithelial tumour: Identification and differential diagnosis in a series of 74 cases. Histopathology. 1999;34:342–356.PubMedCrossRefGoogle Scholar
  9. 9.
    Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer. 2004;101:146–155.PubMedCrossRefGoogle Scholar
  10. 10.
    McManamy CS, Lamont JM, Taylor RE, et al. Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol. 2003;62:627–632.PubMedGoogle Scholar
  11. 11.
    Perry A. Medulloblastomas with Favorable vs. Unfavorable Histology. How Many Small Blue Cell Tumor Types are there in the Brain? Adv Anat Pathol. 2002;9:345–350.PubMedCrossRefGoogle Scholar
  12. 12.
    Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996;85:56–65.PubMedCrossRefGoogle Scholar
  13. 13.
    Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW. Central neurocytoma: A review. J Neuro-Oncol. 2004;66:377–383.CrossRefGoogle Scholar
  14. 14.
    Tamburrini G, Colosimo C, Giangaspero F, Riccardi R, Di Rocco C. Desmoplastic infantile ganglioglioma. Childs Nerv Syst. 2003;19:292–297.PubMedCrossRefGoogle Scholar
  15. 15.
    VandenBerg SR. Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol. 1993;3:275–281.PubMedCrossRefGoogle Scholar
  1. 1.
    Couce, ME, Aker, FV, Scheithauer, BW. Chordoid meningioma. A clinicopathologic study of 42 cases. Am J Surg Pathol 2000;24, 899–905.PubMedCrossRefGoogle Scholar
  2. 2.
    Ecker RD, Marsh WR, Pollock BE, et al. Hemangiopericytoma in the central nervous system: Treatment, pathological features, and long-term follow up in 38 patients. J Neurosurg. 2003;98:1182–1187.PubMedCrossRefGoogle Scholar
  3. 3.
    Ludwin SK, Rubinstein LJ, Russell DS. Papillary meningiomas: a malignant variant of meningioma. Cancer. 1975;36:1363–1373.PubMedCrossRefGoogle Scholar
  4. 4.
    Mena H, Ribas JL, Pezeshkpour GH, et al. Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol. 1991;22:84–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Perry A, Gutmann DH, Reifenberger G. Molecular pathogenesis of meningiomas. J Neuro-Oncol. 2004;70:183–202.CrossRefGoogle Scholar
  6. 6.
    Perry A, Scheithauer BW, Stafford SL, et al. “Rhabdoid” meningioma: an aggressive variant. Am J Surg Pathol. 1998;22:1482–1490.PubMedCrossRefGoogle Scholar
  7. 7.
    Perry A, Stafford SL, Scheithauer BW, et al. “Malignancy” in meningiomas: a clinicopathologic study of 116 patients. Cancer. 1999;85:2046–2056.PubMedGoogle Scholar
  8. 8.
    Rajaram V, Brat DJ, Perry A. Anaplastic meningioma vs. meningeal hemangiopericytoma: Immunohistochemical and genetic markers. Hum Pathol 2004;135:1413–1418.CrossRefGoogle Scholar
  9. 9.
    Tihan T, Viglione M, Rosenblum MC, Olivi A, Burger PC. Solitary fibrous tumors in the central nervous system. A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med. 2003;127:432–439.PubMedGoogle Scholar
  10. 10.
    Zorludemir S, Scheithauer BW, Hirose T, et al. Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol. 1995;19:493–505.PubMedGoogle Scholar

Other Nonglial Neoplasms

  1. 1.
    Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: Report of 248 cases. J Neurosurg. 2000;92:261–266.PubMedCrossRefGoogle Scholar
  2. 2.
    Crotty TB, Scheithauer BW, Youn WF Jr., et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206–214.PubMedCrossRefGoogle Scholar
  3. 3.
    Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48:55–63.PubMedCrossRefGoogle Scholar
  4. 4.
    Hoang MP, Amirkhan RH. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol. 2003;27:1152–1156.PubMedCrossRefGoogle Scholar
  5. 5.
    Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997;86:446–455.PubMedCrossRefGoogle Scholar
  6. 6.
    Paulus W. Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neuro-Oncol. 1999;43:203–208.CrossRefGoogle Scholar
  7. 7.
    Perry A, Parisi JE, Kurtin PJ. Metastatic adenocarcinoma to the brain. An immunohistochemical approach. Hum Pathol. 1997;28:938–943.PubMedCrossRefGoogle Scholar
  8. 8.
    Schild SE, Scheithauer BW, Haddock MG, et al. Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer. 1996;78:2564–2571.PubMedCrossRefGoogle Scholar
  9. 9.
    Srodon M, Westra WH. Immunohistochemical staining for thyroid transcription factor-1: A helpful aid in discerning primary site of tumor origin in patients with brain metastases. Hum Pathol 2002;33:642–645.PubMedCrossRefGoogle Scholar
  10. 10.
    Wolff JEA, Sajedi M, Brant R, Coppes MJ, Egeler RM. Choroid plexus tumours. Br J Cancer. 2002;87:1086–1091.PubMedCrossRefGoogle Scholar

Trauma

  1. 1.
    Croul SE, Flanders AE. Neuropathology of human spinal cord injury. Adv Neurol. 1997;72:317–323.PubMedGoogle Scholar
  2. 2.
    Geddes JF, Whitwell HL, Graham DI. Traumatic axonal injury: Practical issues for diagnosis in medicolegal cases. Neuropathol Appl Neurobiol. 2000;26:105–116.PubMedCrossRefGoogle Scholar
  3. 3.
    Graham DI, Adams JH, Nicoll JAR, et al. The nature, distribution and causes of traumatic brain injury. Brain Pathol. 1995;5:397–406.PubMedCrossRefGoogle Scholar
  4. 4.
    Hardman JM, Manoukian A. Pathology of head trauma. Neuroimaging Clin N Am. 2002;12:175–187.PubMedCrossRefGoogle Scholar
  5. 5.
    Pearl GS. Traumatic neuropathology. Clin Lab Med. 1998;18:39–64.PubMedGoogle Scholar

Ischemic/Anoxic/Vascular Disorders

  1. 1.
    Black M, Graham DI. Sudden unexplained death in adults caused by intracranial pathology. J Clin Pathol. 2002;55:44–50.PubMedGoogle Scholar
  2. 2.
    Kalimo H, Ruchoux MM, Vitanen M, Kalaria RN. CADASIL: A common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 2002;12:371–384.PubMedCrossRefGoogle Scholar
  3. 3.
    Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol. 2002;12:358–370.PubMedGoogle Scholar
  4. 4.
    Pantoni L, Garcia JH. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann New York Acad Sci. 1997;826:92–102.CrossRefGoogle Scholar
  5. 5.
    Parisi JE, Moore PM. The role of biopsy in vasculitis of the central nervous system. Sem Neurol. 1994;14:341–348.CrossRefGoogle Scholar
  6. 6.
    Reevesz T, Holton JL, Lashley T, et al. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol. 2002;12:343–357.CrossRefGoogle Scholar
  7. 7.
    Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997;56:947–964.PubMedCrossRefGoogle Scholar

Neurodegenerative Disorders

  1. 1.
    Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;5:459–466.PubMedCrossRefGoogle Scholar
  2. 2.
    Dickson DW. Neuropathology of Alzheimer’s disease and other dementias. Clin Geriatric Med. 2001;17:209–228.CrossRefGoogle Scholar
  3. 3.
    Forno LS. Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol. 1996;55:259–272.PubMedCrossRefGoogle Scholar
  4. 4.
    Hansen LA, Crain BJ. Making the diagnosis of mixed and non-Alzheimer’s dementias. Arch Pathol Lab Med. 1995;119:1023–1031.PubMedGoogle Scholar
  5. 5.
    Ironside JW. Prion diseases in man. J Pathol. 1998;186:227–234.PubMedCrossRefGoogle Scholar
  6. 6.
    Jellinger KA. Neuropathology of movement disorders. Neurosurg Clin N Am. 1998;9:237–262.PubMedGoogle Scholar
  7. 7.
    Li SH, Li XJ. Huntingtin-protein interactions and the pathogenesis of Huntington’s disease. Trends Genet. 2004;20:146–154.PubMedCrossRefGoogle Scholar
  8. 8.
    Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer’s disease. A primer for practicing pathologists. Arch Pathol Lab Med. 1993;117:132–144.PubMedGoogle Scholar
  9. 9.
    Nance, MA. Clinical aspects of CAG repeat diseases. Brain Pathol. 1997;7:881–900.PubMedCrossRefGoogle Scholar
  10. 10.
    Trojanowski JQ, Dickson D. Update on the neuropathological diagnosis of frontotemporal dementias. J Neuropathol Exp Neurol. 2001;60:1123–1126.PubMedGoogle Scholar
  11. 11.
    Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000;59:931–945.PubMedGoogle Scholar

Inflammatory/Infectious/Demyelinating Diseases

  1. 1.
    Botero D, Tanowitz HB, Weiss LM, Wittner M. Taeniasis and Cysticercosis. Inf Dis Clin N Am. 1993;7:683–697.Google Scholar
  2. 2.
    Burns DK, Risser RC, White CL. The neuropathology of human immunodeficiency virus infection. The Dallas, Texas experience. Arch Pathol Lab Med. 1991;115:1112–1124.PubMedGoogle Scholar
  3. 3.
    Chimelli L, Mahler-Araujo MB. Fungal infections. Brain Pathol. 1997;7:613–627.PubMedCrossRefGoogle Scholar
  4. 4.
    Gray F. Bacterial Infections. Brain Pathol. 1997:7:629–647.PubMedCrossRefGoogle Scholar
  5. 5.
    Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol. 1993;33:18–27.PubMedCrossRefGoogle Scholar
  6. 6.
    Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: A 20-year retrospective series. Hum Pathol. 2002;33:116–124.PubMedCrossRefGoogle Scholar
  7. 7.
    Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol 2001;11:440–451.PubMedCrossRefGoogle Scholar
  8. 8.
    Nowak Da, Widenka DC. Neurosarcoidosis: A review of its intracranial manifestation. J Neurol. 2001;248:363–372.PubMedCrossRefGoogle Scholar
  9. 9.
    Omalu BI, Shakir AA, Wang G, Lipkin WI, Wiley CA. Fatal fulminant pan-meningopolioencephalitis due to West Nile virus. Brain Pathol. 2003;13:465–472.PubMedCrossRefGoogle Scholar
  10. 10.
    Thomas G, Murphy S, Staunton H, O’Neill S, Farrell MA, Brett FM. Pathogen-free granulomatous diseases of the central nervous system. Hum Pathol. 1998;29:1110–1115.CrossRefGoogle Scholar
  11. 11.
    Zagzag D, Miller DC, Kleinman GM, et al. Demyelinating disease versus tumor in surgical neuropathology. Am J Surg Pathol. 1993;17:537–545.PubMedCrossRefGoogle Scholar

Pediatric and Seizure Neuropathology

  1. 1.
    Arai Y, Edwards V, Becker LE. A comparison of cell phenotypes in hemimegalencephaly and tuberous sclerosis. Acta Neuropathol. 1999;98:407–413.PubMedCrossRefGoogle Scholar
  2. 2.
    Black M, Graham DI. Sudden unexplained death in adults caused by intracranial pathology. J Clin Pathol. 2002;55:44–50.PubMedGoogle Scholar
  3. 3.
    Frater JL, Prayson RA, Morris HH, III, Bingaman WE. Surgical pathologic findings of extratemporal-based intractable epilepsy. A study of 133 consecutive resections. Arch Pathol Lab Med. 2000;124:545–549.PubMedGoogle Scholar
  4. 4.
    Golden JA. Holoprosencephaly: A defect in brain patterning. J Neuropathol Exp Neurol. 1998;57:991–999.PubMedCrossRefGoogle Scholar
  5. 5.
    Luyken C, Blumcke I, Fimmers R, et al. The spectrum of long-term epilepsy-associated tumors: Long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia. 2003;44:822–830.PubMedCrossRefGoogle Scholar
  6. 6.
    Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain & Development. 2001;23:508–515.CrossRefGoogle Scholar
  7. 7.
    Norman MG. Malformations of the brain. J Neuropathol Exp Neurol. 1996;55:133–143.PubMedCrossRefGoogle Scholar
  8. 8.
    Pilz D, Stoodley N, Golden JA. Neuronal migration, cerebral cortical development, and cerebral cortical anomalies. J Neuropathol Exp Neurol. 2002;61:1–11.PubMedGoogle Scholar
  9. 9.
    Volpe JJ. Neurologic outcome of prematurity. Arch Neurol. 1998;55:297–300.PubMedCrossRefGoogle Scholar

Toxic/Metabolic Disorders

  1. 1.
    Kolodny EH, Cable WJ. Inborn errors of metabolism. Ann Neurol. 1982;11:221–232.PubMedCrossRefGoogle Scholar
  2. 2.
    Krill JJ. Neuropathology of thiamine deficiency disorders. Metabolic Brain Dis. 1996;11:9–17.CrossRefGoogle Scholar
  3. 3.
    Moser HW, Powers JM, Smith KD. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo’s oil. Brain Pathol. 1995;5:259–266.PubMedCrossRefGoogle Scholar

Sellar/Suprasellar/Pituitary Pathology

  1. 1.
    Gaffey TA, Scheithauer BW, Lloyd RV, et al. Corticotroph carcinoma of the pituitary: A clinicopathological study. Report of four cases. J Neurosurg. 2002;96:352–360.PubMedCrossRefGoogle Scholar
  2. 2.
    Kovacs K, Scheithauer BW, Horvath E, et al. The World Health Organization classification of adenohypophyseal neoplasms. A proposed five-tier scheme. Cancer. 1996;78:502–510.PubMedCrossRefGoogle Scholar
  3. 3.
    Lloyd RV, Scheithauer BW, Kovacs K, Roche PC. The immunophenotype of pituitary adenomas. Endocrine Pathol. 1996;7:145–150.CrossRefGoogle Scholar
  4. 4.
    Pernicone PJ, Scheithauer BW, Horvath E, Kovacs K. Pituitary and sellar region. In: Sternberg SS ed. Diagnostic Surgical Pathology, 2nd Ed., Philadelphia, PA, Lippincott Williams & Wilkins; 1997:1053–1074.Google Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Arie Perry
    • 1
  • Bernd W. Scheithauer
    • 2
    • 3
  1. 1.Division of Neuropathology, Department of Pathology and Laboratory MedicineWashington University School of MedicineSt. Louis
  2. 2.Department of Laboratory Medicine and PathologyMayo ClinicRochester
  3. 3.Mayo Clinic College of MedicineRochester

Personalised recommendations